Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma
暂无分享,去创建一个
M. Taniwaki | H. Kaneko | S. Horiike | J. Kuroda | M. Nakao | N. Uoshima | Y. Shimura | H. Uchiyama | C. Shimazaki | K. Shimura | Y. Chinen | Tsutomu Kobayashi | M. Kiyota | Yutaka Kobayashi | Katsuya Wada | S. Fuchida | K. Tanba
[1] H. Frick,et al. Multiple primary tumours: challenges and approaches, a review , 2017, ESMO Open.
[2] Nicholas M. Donin,et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008 , 2016, Cancer.
[3] Sonali M. Smith,et al. Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Shin Jung,et al. Pineal Diffuse Large B-Cell Lymphoma Concomitant With Pituitary Prolactinoma: Possible Correlation Between 2 Distinguished Pathologies , 2016, Medicine.
[5] P. McLoone,et al. Second primary cancer risk - the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study , 2014, BMC Cancer.
[6] R. Chernock,et al. Human Papillomavirus and Epstein Barr Virus in Head and Neck Carcinomas: Suggestions for the New WHO Classification , 2014, Head and Neck Pathology.
[7] Hiroshi Nishimoto,et al. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. , 2013, Japanese journal of clinical oncology.
[8] K. Karube,et al. Clinicopathological analysis of a composite lymphoma containing both T‐ and B‐cell lymphomas , 2012, Pathology international.
[9] Hsiu‐Po Wang,et al. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. , 2012, Blood.
[10] B. Coiffier,et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. , 2010, Blood.
[11] Carmen L. Wilson,et al. A report from the Childhood Cancer Survivor Study (CCSS): cancer related posttraumatic stress symptoms, depression, anxiety, and chronic pain in adult childhood cancer survivors , 2009 .
[12] U. Demirci,et al. Lymphoproliferative disorders in multiple primary cancers. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[13] R. Arceci,et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study , 2011 .
[14] Matthew J Hayat,et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.
[15] H. Liedloff,et al. Multiple primary malignant tumors , 1970 .